AI-generated summary
This continuing medical education review describes clinical uses of photobiomodulation in dermatology, using red and near-infrared light from lasers or light-emitting diodes. The authors report that studies show PBM can be used effectively for conditions including alopecia, ulcers, acne, wounds, and scars, and that it is noninvasive and has a favorable safety profile. They also state that future clinical trials are needed to produce standardized recommendations across conditions and skin types.
- Who or what was studied
- unclear
- Wavelengths
- 620, 700, 700, 1440 nm
- Limits stated in the abstract
- The abstract describes a review without stating the number of included studies, and it notes that standardized recommendations require future clinical trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 620-700 nm, 700-1440 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.